5
Nov 2024
21:30 E.S.T.

Breaking Barriers in Solid Tumors with SMART allogeneic CAR T-cells

Télécharger le PDF
22
Oct 2024
06:00 E.S.T.

CIRCULARIZATION OF SINGLE-STRANDED DNA TEMPLATE IMPROVES TALEN-MEDIATED GENE INSERTION IN LONG-TERM HSC – ESGCT 2024 – Présentation poster

Télécharger le PDF
22
Oct 2024
06:00 E.S.T.

Controlling C-to-T editing with TALE base editors – ESGCT 2024 – Présentation poster

Télécharger le PDF
10
Mai 2024
19:28 E.S.T.

Circularization of Non-Viral Single-Strand DNA Template for Gene Correction and Gene Insertion Improves Editing Outcomes in HSPCs – ASGCT 2024 – Présentation poster

Télécharger le PDF
9
Mai 2024
12:35 E.S.T.

Intron Editing of HSPC Enables Lineage-Specific Expression of Therapeutics – ASGCT 2024 – Présentation poster

Télécharger le PDF
24
Jan 2024
09:21 E.S.T.

Comprehensive Analysis of the Editing Window of TALE Base Editors – Keystone Symposia “Precision Genome Engineering” – Présentation poster

Télécharger le PDF
24
Jan 2024
09:20 E.S.T.

TALEN®-edited Allogeneic Inducible Dual CAR T-cells Enable Effective Targeting of Solid Tumors – Keystone Symposia “Emerging Cellular Therapies” – Présentation poster

Télécharger le PDF
24
Jan 2024
09:18 E.S.T.

Preclinical efficacy of PD-L1/TGF-beta resistant MUC1-CAR T-cells with inducible IL12 against triple-negative breast cancer – Keystone Symposia « Emerging Cellular Therapies » – Présentation poster

Télécharger le PDF
12
Déc 2023
15:49 E.S.T.

Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T-Cell Product Manufactured by Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ (B-ALL) – ASH 2023 – Présentation Poster

Télécharger le PDF
12
Déc 2023
15:47 E.S.T.

Preliminary Results of NatHaLi-01: A First-In-Human Phase I/IIa Study of UCART20x22, a Dual Allogeneic CAR-T Cell Product Targeting CD20 and CD22, in Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL) – ASH 2023 – Présentation Poster

Télécharger le PDF